Viewing SEC Facts Units
Company Name:
Stoke Therapeutics, Inc.
CIK:
1623526
Start Filing Date:
2022-07-01
End Filing Date:
2022-09-30
ACCN:
0001564590-22-037497
Value:
$ 39,420,310
Value Error:
$ None
Created By:
Date Filed:
2022-11-14
FY:
2022
Fiscal Period:
Q3
Frame:
CY2021Q3
Type:
us-gaap
Form:
10-Q
Units:
shares